Robert Adams G.'s most recent trade in National Health Investors, Inc. was a trade of 32,935 Common Stock done at an average price of $74.7 . Disclosure was reported to the exchange on March 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| National Health Investors,... | Robert G. Adams | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.70 per share. | 28 Mar 2025 | 32,935 | 342,096 (0%) | 0% | 74.7 | 2,460,245 | Common Stock |
| National Health Investors,... | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 25,000 | 0 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors,... | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.41 per share. | 28 Mar 2025 | 25,000 | 355,031 (0%) | 0% | 53.4 | 1,335,250 | Common Stock |
| National Health Investors,... | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 10,000 | 0 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors,... | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 28 Mar 2025 | 10,000 | 375,031 (0%) | 0% | 57.8 | 577,600 | Common Stock |
| National Health Investors,... | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 10,000 | 0 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors,... | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.73 per share. | 28 Mar 2025 | 10,000 | 365,031 (0%) | 0% | 54.7 | 547,300 | Common Stock |
| National Health Investors,... | Robert G. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) 2025 | |
| National Health Investors,... | Robert Adams G. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors,... | Robert G. Adams | Director | 01 Oct 2023 | 85,411 | 0 (0%) | 0% | 0 | Common Stock | ||
| National Health Investors,... | Robert G. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors,... | Robert G. Adams | Director | Purchase of securities on an exchange or from another person at price $ 56.60 per share. | 14 Dec 2022 | 1,000 | 180,548 (0%) | 0% | 56.6 | 56,600 | Common Stock |
| National Health Investors,... | Robert G. Adams | Director | Purchase of securities on an exchange or from another person at price $ 65.93 per share. | 15 Aug 2022 | 1,500 | 85,411 (0%) | 0% | 65.9 | 98,895 | Common Stock |
| National Health Investors,... | Robert G. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors,... | Robert G. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 25,000 | 25,000 | - | - | Stock Options (Right to Buy) 2-25-2021 | |
| National Health Investors,... | Robert G. Adams | Director | Purchase of securities on an exchange or from another person at price $ 67.75 per share. | 14 Dec 2020 | 2,000 | 168,000 (0%) | 0% | 67.8 | 135,500 | Common Stock |
| National Health Investors,... | Robert G. Adams | Director | Purchase of securities on an exchange or from another person at price $ 66.33 per share. | 17 Nov 2020 | 4,000 | 83,911 (0%) | 0% | 66.3 | 265,320 | Common Stock |
| National Health Investors,... | Robert G. Adams | Director | Purchase of securities on an exchange or from another person at price $ 66.45 per share. | 17 Nov 2020 | 1,000 | 79,911 (0%) | 0% | 66.5 | 66,450 | Common Stock |